Semaglutide, a drug used primarily for type 2 diabetes, shows promise in managing non-alcoholic fatty liver disease (NAFLD). This GLP-1 receptor agonist aids in weight loss and improves liver health by reducing fat in the liver, controlling blood sugar, and providing antioxidant and anti-inflammatory benefits. Studies point to significant improvements in liver enzyme levels with minimal side effects.
Health